Skip to main content
. 2022 Aug 2;11:100370. doi: 10.1016/j.ajpc.2022.100370

Fig. 2.

Fig. 2

Variation of Antihyperglycemic Therapy Across United States Counties.

Histograms of the number of Medicare beneficiaries per 100,000 population in U.S. counties receiving (A) metformin, (B) sodium glucose cotransporter 2 inhibitors (SGLT2i), (C) glucagon-like peptide-1 receptor agonists (GLP-1RA).